LONG FACTOR CERTIFICATE - UCB Share Price

YPJ2H

DE000GQ6CVZ9

Market Closed - Euronext Paris 17:28:50 31/05/2024 BST
66.68 ^EUR	+18.52%

Current month	-19.46%
1 month	-19.46%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart UCB

Latest news about UCB

UCB : Acquisition of own shares	05-31	PU
UCB : Commitment to Innovation in Drug Development	05-29	PU
UCB : announces publication in The Lancet of phase 3 bimekizumab▼ trials in moderate to severe hidradenitis suppurativa	05-23	PU
UCB - Acquisition of own shares	05-20	AQ

More news

Quotes 5-day view

Date	Price	Change
31/05/24	68.47	+21.70%
30/05/24	56.26	-7.60%
29/05/24	60.89	-1.06%
28/05/24	61.54	-10.49%
27/05/24	68.75	-2.14%

Real-time Euronext Paris

Last update May 31, 2024 at 05:28 pm

More quotes

Static data

Product type	Produits Exotiques
Buy / Sell	CALL
Underlying	UCB
Issuer	Goldman Sachs
	YPJ2H
ISIN	DE000GQ6CVZ9
Date issued	28/09/2023
Strike	118.1 €
Maturity	Unlimited
Parity	0.16 : 1
Emission price	9.99 €
Emission volume	N/A
Settlement	règlement en espèces
Currency	EUR

Technical Indicators

Highest since issue	91.18 €
Lowest since issue	0.21 €
Spread	3 €
Spread %	4.40%

Company Profile

UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.

Sector

More about the company

Ratings for UCB

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Consensus: UCB

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

128.6 EUR

Average target price

126.4 EUR

Spread / Average Target

-1.76%

Consensus